The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $66.70

Today's change-0.01 -0.01%
Updated December 2 4:00 PM EST. Delayed by at least 15 minutes.
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $66.70

Today's change-0.01 -0.01%
Updated December 2 4:00 PM EST. Delayed by at least 15 minutes.

Seattle Genetics Inc down slightly

Seattle Genetics Inc closed down just (U.S.)$0.01 Friday to (U.S.)$66.70. Shares have lost 7.17% over the last five days, but have gained 48.62% over the last year to date. This security has outperformed the S&P 500 by 57.20% during the last year.

Key company metrics

  • Open(U.S.) $66.41
  • Previous close(U.S.) $66.71
  • High(U.S.) $67.87
  • Low(U.S.) $66.27
  • Bid / Ask(U.S.) $61.27 / (U.S.) $74.75
  • YTD % change+48.62%
  • Volume720,130
  • Average volume (10-day)1,590,901
  • Average volume (1-month)1,495,810
  • Average volume (3-month)1,055,020
  • 52-week range(U.S.) $26.02 to (U.S.) $75.36
  • Beta2.28
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.78
Updated December 2 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue1069511193
Total other revenue--------
Total revenue1069511193
Gross profit958510283
Total cost of revenue11101010
Total operating expense139129132119
Selling / general / administrative35333034
Research & development93869375
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-32-33-21-25
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-32-33-20-25
Income after tax-32-33-20-25
Income tax, total--------
Net income-32-33-20-25
Total adjustments to net income--------
Net income before extra. items-32-33-20-25
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-32-33-20-25
Inc. avail. to common incl. extra. items-32-33-20-25
Diluted net income-32-33-20-25
Dilution adjustment--------
Diluted weighted average shares141140140140
Diluted EPS excluding extraordinary itemsvalue per share-0.23-0.23-0.15-0.18
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.23-0.23-0.15-0.18